BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 3259608)

  • 1. The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro.
    Furue M; Katz SI
    J Immunol; 1988 Jun; 140(12):4139-43. PubMed ID: 3259608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine A inhibits accessory cell and antigen-presenting cell functions of epidermal Langerhans cells.
    Furue M; Katz SI
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):87-91. PubMed ID: 3259044
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance.
    Enk AH; Angeloni VL; Udey MC; Katz SI
    J Immunol; 1993 Sep; 151(5):2390-8. PubMed ID: 8103065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of epidermal Langerhans cell function by low dose ultraviolet B radiation. Ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells.
    Tang A; Udey MC
    J Immunol; 1991 May; 146(10):3347-55. PubMed ID: 1673983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal cells as accessory cells in the generation of allo-reactive and hapten-specific cytotoxic T lymphocyte (CTL) responses.
    Steiner G; Wolff K; Pehamberger H; Stingl G
    J Immunol; 1985 Feb; 134(2):736-41. PubMed ID: 2578162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivity of freshly isolated and cultured murine Langerhans cells to ultraviolet B radiation and chemical fixation.
    Tang A; Udey MC
    Eur J Immunol; 1992 Feb; 22(2):581-6. PubMed ID: 1347017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissection of human Langerhans cells' allostimulatory function: the need for an activation step for full development of accessory function.
    Péguet-Navarro J; Dalbiez-Gauthier C; Dezutter-Dambuyant C; Schmitt D
    Eur J Immunol; 1993 Feb; 23(2):376-82. PubMed ID: 8436173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antigen-presenting capacity of cultured Langerhans' cells is associated with markedly increased expression of Ia antigen.
    Shimada S; Caughman SW; Sharrow SO; Stephany D; Katz SI
    J Immunol; 1987 Oct; 139(8):2551-5. PubMed ID: 3498764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes.
    Streilein JW; Grammer SF
    J Immunol; 1989 Dec; 143(12):3925-33. PubMed ID: 2592763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glucocorticosteroids on epidermal cell-induced immune responses.
    Aberer W; Stingl L; Pogantsch S; Stingl G
    J Immunol; 1984 Aug; 133(2):792-7. PubMed ID: 6610710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine IL-10 partially prevents differentiation of neonatal dendritic epidermal leukocytes into Langerhans cells.
    Chang-Rodriguez S; Ecker R; Stingl G; Elbe-Bürger A
    J Leukoc Biol; 2004 Sep; 76(3):657-66. PubMed ID: 15197230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of physicochemical agents on murine epidermal Langerhans cells and Thy-1-positive dendritic epidermal cells.
    Aberer W; Romani N; Elbe A; Stingl G
    J Immunol; 1986 Feb; 136(4):1210-6. PubMed ID: 2868057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The murine IL 2 receptor. III. Cellular requirements for the induction of IL 2 receptor expression on T cell subpopulations.
    Malek TR; Schmidt JA; Shevach EM
    J Immunol; 1985 Apr; 134(4):2405-13. PubMed ID: 3919092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-stable antigen is an important costimulatory molecule on epidermal Langerhans' cells.
    Enk AH; Katz SI
    J Immunol; 1994 Apr; 152(7):3264-70. PubMed ID: 7908303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential ability of fixed antigen-presenting cells to stimulate nominal antigen-reactive and alloreactive T4 lymphocytes.
    Moreno J; Lipsky PE
    J Immunol; 1986 May; 136(10):3579-87. PubMed ID: 3084635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4+ cells of the T helper 2 subset.
    Simon JC; Cruz PD; Bergstresser PR; Tigelaar RE
    J Immunol; 1990 Oct; 145(7):2087-91. PubMed ID: 1975824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis.
    Will A; Blank C; Röllinghoff M; Moll H
    Eur J Immunol; 1992 Jun; 22(6):1341-7. PubMed ID: 1601029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine inhibits macrophage-mediated antigen presentation.
    Palay DA; Cluff CW; Wentworth PA; Ziegler HK
    J Immunol; 1986 Jun; 136(12):4348-53. PubMed ID: 3486899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.